This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Molecure S.a.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gleb Andryianau: Innovator in Therapeutic Applications
Introduction
Gleb Andryianau is a notable inventor based in Irvine, California. He has made significant contributions to the field of therapeutic applications, particularly through his innovative work on YKL-40 inhibitors. His research focuses on the interactions of chitinase-like protein YKL-40, which has implications for various biological processes.
Latest Patents
Gleb Andryianau holds a patent related to YKL-40 inhibitors. The patent discloses assays for screening active compounds that interfere with the interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as with heparan sulfate. Additionally, the patent identifies active compounds as inhibitors of YKL-40, detailing their therapeutic applications and their use in biosensors for measuring YKL-40 levels in biological samples. He has 1 patent to his name.
Career Highlights
Gleb Andryianau is associated with Molecure S.A., where he continues to advance his research in the field of biotechnology. His work has the potential to lead to significant breakthroughs in therapeutic treatments.
Collaborations
He has collaborated with notable colleagues, including Łukasz Krzemiński and Wojciech J Czestkowski, contributing to a dynamic research environment.
Conclusion
Gleb Andryianau's innovative work on YKL-40 inhibitors showcases his commitment to advancing therapeutic applications in biotechnology. His contributions are paving the way for future developments in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile